Clinical Trial Update: Neuromodulation for a Novel OCD Biomarker and Treatment [NA]

View source ↗

Summary

A Boston University study is currently recruiting to assess a neuromodulation approach targeting a novel OCD biomarker as a potential treatment.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obsessive-compulsive Disorder

Snippet

Sponsor: Boston University Charles River Campus | Conditions: OCD | NA | Status: RECRUITING